A
ACCURAY INCORPORATED
NASDAQ: ARAY (Accuray Incorporated)
Last update: 15 minutes ago2.80
-0.28 (-9.09%)
| Previous Close | 3.08 |
| Volume | 140,573 |
| Price / Sales | 0.020 |
| Price / Book | 0.170 |
| 52 Weeks Range |
| Profit Margin | 0.14% |
| Operating Margin (TTM) | 3.73% |
| Quarterly Revenue Growth (YOY) | 16.80% |
| Total Debt/Equity (MRQ) | 289.67% |
| Current Ratio (MRQ) | 1.64 |
| Operating Cash Flow (TTM) | 22.45 M |
| Levered Free Cash Flow (TTM) | 23.73 M |
| Return on Assets (TTM) | 1.72% |
| Return on Equity (TTM) | 1.48% |
AIStockmoo Score
| Value 38% | -1.3 |
| AI Insight info | NA |
| Relative Valuation info | NA |
| Financial Health info | -1.3 |
| Timing 38% | -2.5 |
| AI Technical info | NA |
| Technical Oscillators info | -2.5 |
| Technical Moving Averages info | -2.5 |
| Sentiment 25% | 0.0 |
| Analyst Consensus info | 0.0 |
| News Mood info | NA |
| Smart Money | NA |
| Insider Activity info | NA |
| Institutional Flow info | NA |
| Short Interest info | NA |
| Environment | ×1.16 |
| Macro Environment info | -3.3 |
| Sector vs Market (6M) | -5.7% |
| Pillar Agreement | ×1.25 |
| Not in score | |
| Price Volatility info | 1.5 |
| Final Score | -2.07 |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Accuray Incorporated | Mixed | Bearish |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| ARAY | - | - | - | 0.170 |
| ZIMV | 535 M | - | - | 1.29 |
| KIDS | - | - | - | 2.61 |
| NPCE | - | - | - | 38.49 |
| BRKR | - | 0.32% | - | 4.10 |
| CLPT | - | - | - | 10.76 |
Select this tab to load the latest available analysis.
|
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 2.27% |
| % Held by Institutions | 62.55% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Tcw Group Inc | 30 Sep 2026 | 688,198 |
| Vanguard Group Inc | 31 Dec 2025 | 145,464 |
| Armistice Capital, Llc | 30 Jun 2026 | 143,400 |
| Neuberger Berman Group Llc | 30 Sep 2026 | 134,620 |
| Weber Capital Management Llc /Adv | 30 Sep 2026 | 120,815 |
| Vanguard Capital Management Llc | 30 Sep 2026 | 110,779 |
| Aqr Capital Management Llc | 30 Jun 2026 | 67,976 |
| Renaissance Technologies Llc | 30 Sep 2026 | 49,757 |
| Dafna Capital Management Llc | 30 Jun 2026 | 42,013 |
| Fmr Llc | 30 Sep 2026 | 39,881 |
| Millennium Management Llc | 30 Jun 2026 | 39,729 |
| Silverback Asset Management Llc | 30 Jun 2026 | 36,250 |
| Geode Capital Management, Llc | 30 Sep 2026 | 31,831 |
| Kovack Advisors, Inc. | 30 Sep 2026 | 28,149 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 13 Nov 2026 | Yahoo Finance |
Accuray Closes TCW Transaction, Strengthening Balance Sheet to Support Long-Term Value Growth
Accuray Incorporated (NASDAQ: ARAY) today announced that it has completed its financing transaction with TCW Asset Management Company LLC ("TCW"), the company's primary lender and largest shareholder. The transaction significantly reduces Accuray's debt, adds new capital and waives certain… |
| 05 Nov 2026 | Yahoo Finance |
Accuray (ARAY) Q1 2027 Earnings Call Transcript
Service margins and cost cuts offset a product revenue slide. |
| 05 Nov 2026 | Yahoo Finance |
Accuray Incorporated Q1 2027 Earnings Call Summary
Moby summary of Accuray Incorporated's Q1 2027 earnings call… |
| 05 Nov 2026 | Yahoo Finance |
Accuray Inc (ARAY) (Q1 2027) Earnings Call Highlights: Service Strength and Cost Cuts Offset by ...
Accuray Inc (ARAY) posted 4% service revenue growth and a $2.5 million adjusted EBITDA profit, but an 8% total revenue decline and weak product orders weighed on the quarter. |
| 04 Nov 2026 | Yahoo Finance |
RaySearch Laboratories AB (RSLBF) (Q3 2026) Earnings Call Highlights: Record Sales and 18% ...
RaySearch Laboratories AB (RSLBF) posted record Q3 2026 sales of SEK 394 million with license orders up 65%, though a softer license sales mix and negative free cash flow tempered the quarter. |
| 04 Nov 2026 | Yahoo Finance |
Accuray: Fiscal Q1 Earnings Snapshot
(ARAY) on Wednesday reported fiscal first-quarter net income of $10.1 million, after reporting a loss in the same period a year earlier. |
| 04 Nov 2026 | Yahoo Finance |
Accuray Announces 1-for-40 Reverse Stock Split
Accuray Incorporated (NASDAQ: ARAY) announced today that its Board of Directors has approved a 1-for-40 reverse stock split of the Company's common stock and a corresponding decrease to the authorized number of shares of common stock. The reverse stock split is intended to increase the per-share… |
| 04 Nov 2026 | Yahoo Finance |
Accuray Reports Fiscal 2027 First Quarter Financial Results
Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter ended September 30, 2026… |
| 30 Oct 2026 | Yahoo Finance |
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Sofiane Laoussadi, the company's new Senior Vice President, Global Services & Solutions. |
| 21 Oct 2026 | Yahoo Finance |
Accuray to Report First Quarter Fiscal 2027 Financial Results on November 4, 2026
Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2027, ended September 30, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on November 4, 2026… |
| 06 Oct 2026 | Yahoo Finance |
Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director
Accuray Incorporated (Nasdaq: ARAY) today announced that stockholders approved all proposals presented at the company's Special Meeting of Stockholders held on October 6, 2026, enabling Accuray to complete its previously announced transactions with TCW Asset Management Company LLC, the company's… |
| 28 Sep 2026 | Yahoo Finance |
Accuray partners with Samsung NeuroLogica on CyberKnife imaging
The agreements bring together mobile CT capabilities and precision treatment delivery expertise to improve anatomical visualisation during radiotherapy. |
| 27 Sep 2026 | Yahoo Finance |
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform
Accuray Incorporated (NASDAQ: ARAY) today announced that it had entered into agreements with Samsung HME America, Inc., dba NeuroLogica Corp. ("Samsung NeuroLogica") to pursue advanced volumetric imaging capabilities for the CyberKnife® System. The announcement coincides with the American Society… |
| 14 Sep 2026 | Yahoo Finance |
What Accuray’s (ARAY) $8 Million RaySearch Deal Means for Its Adaptive Therapy Push
Accuray Inc.’s (NASDAQ:ARAY) recent agreement with RaySearch Laboratories around an extended alliance, is a major step toward online adaptive radiation therapy. The integration of Accuray’s imaging technology and photon-based radiation therapy platforms with RaySearch’s proprietary planning and… |
| 11 Sep 2026 | Yahoo Finance |
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities
Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, and RaySearch Laboratories AB (publ) today announced that they had entered into a definitive agreement providing for an expanded collaboration aimed at accelerating Accuray's adoption of… |
| 28 Aug 2026 | Yahoo Finance |
Balance Sheet Rescue Meets China Drag in Accuray’s (ARAY) Mixed Quarter
On August 19, Accuray Incorporated (NASDAQ:ARAY) held its fiscal fourth-quarter and full-year 2026 earnings call, laying out a business caught between a genuine financial rescue and a China market that is still bleeding revenue. Total net revenue fell 21% in the quarter to $100.9 million, and the… |
| 26 Aug 2026 | Yahoo Finance |
Accuray (ARAY) Q4 2026 Earnings Call Transcript
Transformation plan delivered $20M in cost savings as China headwinds pressured product revenue 42%. |
| 20 Aug 2026 | Yahoo Finance |
Accuray Inc (ARAY) (Q4 2026) Earnings Call Highlights: Strategic Transformation and Financial ...
Accuray exceeds cost-saving targets and strengthens balance sheet through TCW deal, despite revenue headwinds from China and tariff pressures. |
| 19 Aug 2026 | Yahoo Finance |
Accuray Incorporated Q4 2026 Earnings Call Summary
Moby summary of Accuray Incorporated's Q4 2026 earnings call… |
| 19 Aug 2026 | Yahoo Finance |
Accuray Reports Fourth Quarter and Fiscal 2026 Financial Results
Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal 2026, ended June 30, 2026… |
| Show more | ||
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |